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Neuropsychiatric Symptoms as The First Manifestation of Juvenile Systemic 
Lupus Erythematosus: A Complicated Case with Klinefelter’s Syndrome
Abstract
Systemic Lupus Erythematosus (SLE) is an autoimmune, multisystem disorder 
with various manifestations. There are limited reports on the neuropsychiatric 
findings as the first manifestation of SLE in children. Herein, we report a 
14-year-old Iranian boy with a two-year history of cognitive dysfunction and 
behavioural problems as well as a recent history of epistaxis. The patient work-
up ended with a diagnosis of Klinefelter’s syndrome associated with juvenile 
SLE. Patients with Klinefelter’s syndrome may exhibit behavioural problems 
and psychological disease. These psychiatric disorders could be complicated 
with lupus in children. In fact, psychiatric symptoms may occur as the first 
manifestation of juvenile SLE. Specially, if accompanied with Klinefelter’s 
syndrome. We suggest the diagnosis of SLE must be considered in all children 
with neuropsychiatric manifestations.
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CASE REPORT
Introduction
Systemic Lupus Erythematosus (SLE) is an autoimmune, inflammatory disorder 
affecting multiple organ systems (1). The nervous system is affected in more than 
half of all patients during the course of the disease, both in children and adults, 
and its involvement is associated with a worse prognosis and more cumulative 
damage (2, 3). Neuropsychiatric Lupus (NPSLE) manifestations can occur in 
the absence of either serologic activity or other systemic disease manifestations 
(4). Patients with Klinefelter’s syndrome (KFS) show a higher percent of SLE 
diseases than the normal population (5). On the other hand, psychiatric disorders 
involving anxiety, depression, neurosis, and psychosis are more common in this 
group than in the general population (6). SLE may be the first presenting symptom 
of Klinefelter’s syndrome and lead to a diagnosis of the disease (7). Herein, we 
present a case with Klinefelter’s syndrome and psychiatric disorders. In due 
course, this patient exhibited clinical features of SLE and was diagnosed with a 
case of neuropsychiatric lupus associated with KFS.
Case presentation
A fourteen year-old Iranian boy who suffered from headaches and lethargy for two 
years was admitted to Mofid Children’s Hospital. During the two years, he had 
demonstrated aggressive behaviour, a loss of school performance, stuttering of 
nails, and eyelash and eyebrow ablation. Last year, he was admitted to a psychiatric 
centre because of behavioural, memory, and psychiatric problems. He received 
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His Karyotyping revealed 47 XXY, which is diagnostic 
for Klinefelter’s syndrome (Fig. 1). 
The patient fulfilled the ACR classification Criteria 
(revised 1997) for juvenile SLE (8). Therefore, 
he was treated with parenteral corticosteroids and 
cyclophosphamide pulse therapy. After two weeks 
of treatment, his neuropsychiatric symptoms and 
thrombocytopenia began to normalize. 
Discussion 
SLE is a chronic autoimmune disease characterized by 
multisystemic involvement and diverse manifestations 
(9). Central nervous system involvement remains a 
major cause of morbidity and mortality in these types of 
patients (10). The overall prevalence of major NPSLE 
varies among series. It ranges widely between 22% and 
95% in children to reflect variable diagnostic criteria 
and the difficulty in defining psychiatric abnormalities 
as well as differences in selection of patients for 
study (1, 7, 13). ACR has developed a standardized 
nomenclature system that provides case definitions 
for neuropsychiatric syndromes in SLE (10, 12). In 
the only prospective study of NPSLE in children, 
nervous system manifestations were more common 
over a 6-year study period than glomerulonephritis 
(95% versus 55%) (14). Headaches occurred in 55%, 
various treatments, including speech therapy, physical 
therapy, and psychotherapy. None of these measures 
was helpful and he continued the abnormal behaviour. 
For the last  month, he suffered from epistaxis and 
easy bruising, for which, he was again referred to 
Mofid Children’s Hospital. During admission, he 
showed photosensitivity and photophobia. On physical 
examination, his eyebrows and eyelashes were absent 
and he had no nails on fingers. He had oral ulcers, 
scant facial and body hair, multiple ecchymoses, 
and petechiae on his body. The laboratory findings 
revealed thrombocytopenia with positive titres of 
antinuclear antibodies (ANA), anti-double stranded 
DNA antibody, antiphospholipid antibody, and low 
titres of C3 and C4. There was neither anaemia nor 
leukopenia. The results of direct and indirect Coombs 
tests were negative. His bone marrow aspiration and 
coagulation profile were normal. Results of other blood 
tests were within normal limits or negative, including 
lupus anticoagulant, ß2-glycoprotein, anticardiolipin 
IgG and IgM Abs, anti-RO, anti-LA, anti-SM Ab, P 
& C-ANCA, VDRL, TSH, FT4, anti-T microsomal, 
antithyroglobulin, cryoglobulins, AntiHIV antibody 
hepatitis C antibodies, hepatitis B antigen, protein C 
activity, and protein S free. He had no evidence of 
uveitis or vasculitis and his brain MRI was normal. 
Neuropsychiatric Symptoms as The First Manifestation of Juvenile Systemic Lupus Erythematosus: A Complicated ...
Fig 1. 10 metaphase spreads from a bone marrow sample and 15 metaphase spreads from peripheral blood sample 
were studied based on GTG technique at 400-450 band resolution, revealing 47-XXY pattern.
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especially in those who do not respond well to the 
classic psychiatric treatments, a diagnosis of SLE must 
be strongly considered.
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